OBJECTIVES: Resection of a long pulmonary artery (PA) segment infiltrated by tumour and reconstruction by conduit interposition or wide patch is a challenging but feasible option to avoid pneumonectomy. Our goal was to report the long-term results of our experience with this type of operation using various techniques and materials.
INTRODUCTION
Resection and reconstruction of the pulmonary artery (PA) is a reliable therapeutic option to avoid pneumonectomy (PN) for patients with centrally located lung cancer who cannot be treated radically with a standard lobectomy. This parenchymal sparing operation is generally considered in patients with limited longitudinal extension of the vascular infiltration, whereas a PN is usually required in the presence of extended arterial involvement [1] [2] [3] [4] [5] [6] [7] [8] .
Technical difficulties of PA reconstruction increase when the tumour infiltration involves a long segment requiring an extended vessel resection. In such cases, circumferential (sleeve) resection of the PA always produces a wide distance between the 2 vascular stumps with consequent high tension on the direct anastomosis [5] . After sleeve resection with excessive distance between the 2 vascular stumps, a conduit interposition has been reported to be a feasible and effective reconstructive option in our and others' few experiences [9] [10] [11] . However, this procedure is still used infrequently by thoracic surgeons because of the technical complexity and related risk of complications.
Similarly, reconstruction after extended partial resection of only 1 aspect of the arterial wall for a tumour that has invaded less than half of the vessel circumference may be demanding. We have proved the feasibility of PA reconstruction with a wide patch after extended arterial resection limited to 1 aspect of the vessel [12, 13] .
We report the long-term results of a series of patients with centrally located lung cancer who underwent conduit or wide patch reconstruction after extended resection of the PA associated with lobectomy.
MATERIALS AND METHODS
Between 1991 and 2015, 24 patients underwent sleeve resection of a long PA segment (20 patients) or extended resection (longitudinal axis >2.5 cm) of 1 aspect of the PA (4 patients) associated with lobectomy for centrally located lung cancer (Fig. 1) . Vascular reconstruction in the 20 patients who received PA sleeve resection was performed with a conduit interposition, whereas a wide patch reconstruction was performed in 4 patients who received a partial resection of the PA wall limited to 1 aspect of the vessel circumference. Twenty-three patients underwent left upper lobectomy associated with the vascular reconstruction (19 patients by conduit reconstruction and 4 patients by wide patch reconstruction) without bronchoplasty. One patient underwent bronchovascular left upper sleeve lobectomy with conduit reconstruction of the PA. Twenty of these patients (including all those receiving wide patch repair) were operated on since 2006. Sleeve resection of the PA was required in 20 patients due to tumour infiltration involving over one-half of the vessel circumference. Partial resection was performed in patients showing infiltration of only 1 aspect of the PA for less than one-half of its circumference. Materials used for conduit reconstruction after sleeve resection (20 patients) were all biological and included pulmonary vein (PV) in 12 ( Fig. 2) patients, autologous pericardium in 4, porcine pericardium in 3 ( Fig. 3 ) and bovine pericardium in 1. Patches used in 4 patients consisted of porcine pericardium (2 patients) and PV (2 patients) (Fig. 4) .
The indication for a conduit reconstruction was excessive distance between the 2 vascular stumps after PA sleeve resection that predisposed the patient to high anastomotic tension in case of a direct suture. Our preference in all cases was for biological materials. In the first period of our experience, we preferred autologous or heterologous pericardial conduit. Since 2009, our preferred option has been the superior PV graft in all patients with tumour not adjacent to the extraparenchymal portion of the vein. Porcine pericardium has been available only more recently, and in the last few years, we preferred it to the bovine pericardium, as an alternative to the PV.
Also for wide patch reconstruction, our preference in the last few years has been the PV, when available and free of tumours. Porcine pericardium was used as the preferred alternative in this series.
The study was approved by the local ethics committee and conducted in accordance with the Declaration of Helsinki. All patients provided written informed consent for the operation and for the inclusion of personal data in a scientific database.
Preoperative workup and staging included contrast-enhanced thoracic and abdominal computed tomography (CT), brain CT or magnetic resonance imaging and bone scintigraphy if indicated. Since 2004, we have performed F-18 fluorodeoxyglucose wholebody positron emission tomography (PET) if preoperative cytological-or histological-specific diagnosis on the primary tumour was not achieved or in case of doubt of the presence of metastatic lesions.
The preoperative clinical evaluation to assess the operability of patients also included respiratory function tests and blood gas analysis. Perfusion lung scintigraphy was performed in case of doubt about functional resectability. Bronchoscopy was performed in all patients to assess the potential involvement of the bronchial tree. Mediastinoscopy was performed in the presence of enlarged peritracheal or subcarinal lymph nodes (long-axis diameter >1.5 cm) on CT scan. Patients with histologically or cytologically proven metastatic mediastinal lymphadenopathy underwent induction chemotherapy. Since 2004, mediastinal restaging after chemotherapy and before the operation was performed by PET-CT scan and with contrast-enhanced CT scan before 2004. Transbronchial needle aspiration was performed only in selected patients in case of doubt of N2 disease persistence after induction therapy. All patients presented N0-1 preoperative clinical status, some after induction therapy. Systematic hilar and mediastinal lymphadenectomy was performed in all patients.
Postoperative oncological follow-up was performed with contrast-enhanced total body CT scan, bone scintigraphy and with fluorodeoxyglucose-PET since 2004. Follow-up visits were planned every 6 months for the first 5 years. All living patients were available for follow-up for the first 5 years. The last date of follow-up was 30 April 2016.
Surgical technique
We used a lateral muscle-sparing thoracotomy in all patients. Once we achieved full control of the PA, we started the resection phase after the vessel was clamped proximally (intra-or extrapericardially) and distally to the area infiltrated by the tumour. We used systemic heparinization before arterial clamping as a standard practice in all reconstructive procedures. The dose of intravenous heparin represents the only intraoperative management modification adopted over time. In the last 15 years, we preferred to administer 1500-2000 units (25 units/kg) instead of the 3000-5000 units used in the past. We have decreased the dose of heparin to reduce the risk of postoperative oozing, especially from the lymphadenectomy sites, which has showed similar efficacy in thrombosis prevention. In our practice, once the vascular reconstruction has been completed [5, 14] , heparin is not reversed by protamine after declamping.
Frozen section analysis is routinely performed on PA margins. In the case of positive PA margins, we consider PN to be indicated. Conduits or patches used for reconstruction are harvested and sized intraoperatively. Conduit and patch sizes are generally measured to match those of the resected arterial portion.
Techniques for harvesting and constructing the autologous (PV and pericardium) or heterologous (bovine or porcine pericardium) biological conduit or patch have been described in previous papers [5, 9, 10, 12-15].
In case of conduit interposition, the proximal anastomosis was performed first with a running 5-0 monofilament (Prolene) suture. After the conduit length was checked, the distal anastomosis was then performed with the same technique. In patients receiving a patch reconstruction, the patch was sutured to the vascular wall with a running 5-0 Prolene suture. In the postoperative period, low-dose anticoagulation therapy (low-weight heparin 6000-8000 units/day subcutaneously) was administered for 1 week to reduce the risk of thrombosis. No anticoagulation was used after discharge if not required for patient cardiovascular morbidity.
Statistical analysis
The data were collected and stored in an Excel database (Microsoft Corp., Redmond, WA, USA). All statistical analyses were performed using IBM-SPSS Statistics, 21.0.0.0 version. Quantitative variables were expressed as mean ± standard deviation. Overall survival and disease-free survival were estimated with the Kaplan-Meier method.
RESULTS
Fifteen patients were men and 9 were women. The mean age was 60.4 ± 9.8 (range 43-77) years.
Significant comorbidity was present in 11 patients (cardiac ischaemic disease in 3, diabetes in 1, chronic obstructive pulmonary disease in 5, renal insufficiency in 1 and chronic atrial fibrillation in 1). The mean preoperative forced expiratory volume in 1 s was 91.3 ± 5.9% predicted (range 68.9-112.2%).
TNM status at the time of diagnosis (based on CT and PET findings and the results of invasive mediastinal staging when performed) was T2a N0 M0 in 2 patients, T3 N0 M0 in 4, T1b N1 M0 in 5, T2a N1 M0 in 5, T1b N2 M0 in 2, T2a N2 M0 in 4 and T3 N2 M0 in 2.
Preoperative mediastinal node involvement was assessed by mediastinoscopy in 8 patients who subsequently underwent induction chemotherapy. All 8 patients with histologically proven N2 disease presented no evidence of persistent mediastinal involvement after chemotherapy at clinical re-evaluation performed by PET-CT scan.
The mean PA clamping time was 24 ± 4 min. The histological findings were adenocarcinoma in 12 patients, squamous cell carcinoma in 8, large cell neuroendocrine carcinoma in 3 and sarcomatoid carcinoma in 1.
The pathological stage was T1b N0 in 3 patients after induction chemotherapy, T2a N0 in 4, T2b N0 in 2, T3 N0 in 2, T1b N1 in 1, T2a N1 in 3 (2 after induction chemotherapy), T2a N2 in 1, T3 N1 in 4 and T3 N2 in 4 (3 after induction chemotherapy). Radical resection (R0) was achieved in all patients. The PA wall was directly infiltrated by the tumour in 10 patients, whereas it was infiltrated by metastatic hilar nodes in 11 patients. In the remaining 3 patients, the arterial wall was involved in diffuse desmoplastic reaction and scar tissue consequent to induction therapy, precluding the possibility of a standard lobectomy.
The postoperative morbidity rate was 29.1% (1 chylothorax, 3 atrial fibrillation, 1 parenchymal atelectasis, 1 pericarditis and 1 bleeding requiring rethoracotomy). No complications related to the reconstructive procedure occurred. We did not observe differences in bleeding potential among the different reconstructive procedures. There were no postoperative deaths. The mean postoperative hospitalization stay was 6.1 ± 2.4 (range 4-12) days. Fourteen patients underwent adjuvant chemotherapy.
Complete patency of the reconstructed PA was seen in all patients on the postoperative contrast CT scans performed every 6 months. In particular, we have not observed any significant stenosis, late aneurysmal problem or calcification of the reconstructed vessel. The first CT scan to assess PA patency was performed at discharge. Five-year overall survival and disease-free survival rates were 69.9% and 52.7% (Figs 5 and 6) , respectively, at a median follow-up period of 41 (range 6-72) months. Tumour recurrence was observed in 8 (33.3%) patients (3 local and 5 systemic).
No evidence of recurrence was found at the site of the vascular reconstruction on CT and PET scans.
DISCUSSION
Our experience over the last 3 decades proves the technical feasibility and oncological reliability of PA reconstruction even after extended arterial sleeve resection in the presence of widely spaced vascular stumps using a conduit interposition of biological material [8, 9, 14] . The reliability of this reconstructive procedure has been confirmed in a few other limited experiences worldwide with the use of various prosthetic materials including synthetic and biological options [11, [16] [17] [18] .
The present experience shows that even extended arterial resection of only 1 aspect of the PA that leaves large defects (of more than 2.5 cm in maximum longitudinal diameter) can be safely repaired with a biological wide patch reconstruction, thereby avoiding PN.
We prefer biological materials for all types of prosthetic PA reconstructions. During the period of the study, we used various biological options for either conduit or patch reconstruction. During the first part of our experience, autologous or heterologous (bovine) pericardium was our first choice for these procedures.
In particular, we used autologous pericardium more frequently since the beginning of our experience because of its several advantages: adequate thickness and resistance, freedom from cost, availability on both sides of the chest, superior biocompatibility compared with heterologous tissues and an adequate amount of tissue even for the repair of large defects [9] . More recently, we devised a method of fixation of the pericardial leaflet using a glutaraldehyde-buffered solution to improve the characteristics of this tissue [15] . This procedure confers higher rigidity to the pericardial leaflet, thereby reducing its tendency to shrink and curl and making it easier to adapt and suture to the vascular wall. Bovine pericardium has been used as a valid alternative to autologous pericardium because of technical advantages such as greater stiffness and margin regularity. Porcine pericardium has been available only recently and is preferred to bovine pericardium because it shows similar characteristics but is thinner and therefore more similar to the arterial wall [13] .
Since 2009, we have used the PV for conduit reconstruction of the PA because we found that it offered significant advantages that overcame those of the autologous and heterologous pericardia. The PV provides a ready-to-use conduit with appropriate length and calibre and adequate stiffness of the vascular wall; therefore, it does not require an intraoperative longitudinal suture such as that needed for the construction of the pericardial graft [14] . Resistance and elasticity of the PV tissue are also similar to those of the PA wall. On the basis of these observations, we have extended the use of PV to patch repair of the PA.
The oncological reliability of the PV conduit is supported by the absence of local recurrence at the level of the vascular reconstruction observed in our medium and long-term results. This evidence proves that the potential risk of microscopic tumour infiltration of the venous tissue used for arterial reconstruction can be avoided if this technical option is performed in patients with tumour not close to the PV. On the basis of the safety and oncological reliability of the different options we used for conduit PA reconstruction, over the last years, we have extended the indication for this procedure. We have used it in every technical situation showing widely spaced vascular stumps after PA circumferential resection that could be at risk for high tension on the anastomotic suture, instead of performing extensive release manoeuvres including inferior pulmonary ligament section and pericardial release [14] . Excessive anastomotic tension may be more frequently observed on the left side, especially when the vascular sleeve resection is not associated with a bronchial sleeve resection.
Other authors have reported long-term patency and survival in a few selected patients with the use of biological tissues for conduit reconstruction of the PA [15, 16, 19] . The PV has been successfully used in 2 recent case reports [15, 16] . In another recent Spanish experience, Berthet et al. [19] reported the results of a series of 10 patients who underwent PA replacement by cryopreserved allograft (PA or aorta) harvested from multiorgan donors. They observed a 10% graft thrombosis rate, no perioperative mortality and a 66% overall 5-year survival rate.
Synthetic materials have found limited acceptance because of the higher risk of thrombosis and infection and the need for long-term anticoagulation. Among these, polytetrafluoroethylene is considered the first choice, but its use remains occasional [11] .
Perioperative outcome and long-term survival of the few patients reported in the literature receiving conduit reconstruction of the PA are in line with those of other parenchymal sparing resections allowing functional advantages and comparable oncological radicality with respect to PN [20] [21] [22] [23] .
Similarly, so far, patch reconstruction of the PA has been reported to be a safe and oncologically reliable technique for lung tumour with limited infiltration of the vessel [20] . The main concern in performing this reconstructive procedure for more extended invasion of the PA (as in this series) is related to the potential risk of kinking or torsion of the vessel. The present experience shows that even wide patch reconstruction can be accomplished without increased risk of complication and impaired blood flow related to the vascular procedure. This finding proves that, in selected cases showing an extended neoplastic infiltration of the PA limited to 1 aspect of the vessel for less than half of its circumference, PN can be avoided without performing a vascular sleeve resection.
CONCLUSION
Resection of a long PA segment followed by conduit or wide patch reconstruction is a feasible, safe and effective option to avoid PN. Different biological materials can be used to provide adequate tissue characteristics; the choice is made on a case-bycase basis. Long-term results confirm the oncological reliability of this operation.
